Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Jones

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy AdolescentsTimo Vesikari, Lars Østergaard, Javier Diez-Domingo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2024
Amplitude-determined seizure-threshold, electric field modeling, and electroconvulsive therapy antidepressant and cognitive outcomesChristopher C Abbott, Jeremy Miller, Danielle Farrar, et al.
The New England Journal of Medicine|December 14, 2017
A Bivalent Meningococcal B Vaccine in Adolescents and Young AdultsLars Ostergaard, Timo Vesikari, Judith Absalon, et al.
Frontiers in Human Neuroscience|October 31, 2022
Transcranial direct current stimulation modulates working memory and prefrontal-insula connectivity after mild-moderate traumatic brain injuryDavin K Quinn, Jacqueline Story-Remer, Emma Brandt, et al.
Frontiers in Psychiatry|August 18, 2023
Electric field distribution predicts efficacy of accelerated intermittent theta burst stimulation for late-life depressionDavin K Quinn, Joel Upston, Thomas R Jones, et al.
Vaccine|February 10, 2009
Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharideLisa K McNeil, Ellen Murphy, Xiao-Juan Zhao, et al.
The Pediatric Infectious Disease Journal|December 15, 2010
Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trialMatthew D Snape, Chaam L Klinger, Elvis D Daniels, et al.
Antibiotics (Basel, Switzerland)|April 23, 2022
Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive BacteriaDavid M P De Oliveira, Bernhard Keller, Andrew J Hayes, et al.
Vaccine|July 13, 2010
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal diseaseHan-Qing Jiang, Susan K Hoiseth, Shannon L Harris, et al.
Journal of Medicinal Chemistry|May 30, 2003
Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinityRichard W Friesen, Yves Ducharme, Richard G Ball, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy AdolescentsTimo Vesikari, Lars Østergaard, Javier Diez-Domingo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2024
Amplitude-determined seizure-threshold, electric field modeling, and electroconvulsive therapy antidepressant and cognitive outcomesChristopher C Abbott, Jeremy Miller, Danielle Farrar, et al.
The New England Journal of Medicine|December 14, 2017
A Bivalent Meningococcal B Vaccine in Adolescents and Young AdultsLars Ostergaard, Timo Vesikari, Judith Absalon, et al.
Frontiers in Human Neuroscience|October 31, 2022
Transcranial direct current stimulation modulates working memory and prefrontal-insula connectivity after mild-moderate traumatic brain injuryDavin K Quinn, Jacqueline Story-Remer, Emma Brandt, et al.
Frontiers in Psychiatry|August 18, 2023
Electric field distribution predicts efficacy of accelerated intermittent theta burst stimulation for late-life depressionDavin K Quinn, Joel Upston, Thomas R Jones, et al.
Vaccine|February 10, 2009
Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharideLisa K McNeil, Ellen Murphy, Xiao-Juan Zhao, et al.
The Pediatric Infectious Disease Journal|December 15, 2010
Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trialMatthew D Snape, Chaam L Klinger, Elvis D Daniels, et al.
Antibiotics (Basel, Switzerland)|April 23, 2022
Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive BacteriaDavid M P De Oliveira, Bernhard Keller, Andrew J Hayes, et al.
Vaccine|July 13, 2010
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal diseaseHan-Qing Jiang, Susan K Hoiseth, Shannon L Harris, et al.
Journal of Medicinal Chemistry|May 30, 2003
Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinityRichard W Friesen, Yves Ducharme, Richard G Ball, et al.
Pageof 7